English (United States)|Italiano (Italia)
English (United States) | Italiano (Italia)
Article details
02 March 2016 - Market launch of Akynzeo

Market launch of Akynzeo, new NK-1 antagonist serotonergic

Market launch of Akynzeo, new NK-1 antagonist serotonergic (combination of Palonosetron + netupitant) in fixed-dose oral formulation.

The event's picture: